Skip to main content
. 2016 Jul-Aug;27(4):252–257. doi: 10.5830/CVJA-2016-007

Table 2. Gender distribution of the study groups.

Groups Male, n (%) Female, n (%) Total, n (%)
HAART 51 (51.0) 49 (49.0) 100 (100)
HAART-naive 48 (48.0) 52 (52.0) 100 (100)
Control 52 (52.0) 48 (48.0) 100 (100)
Total 151 (50.3) 149 (49.7) 300 (100)

χ2 = 0.347, p = 0.841. HAART = highly active antiretroviral therapy.